| Patent application number | Description | Published |
|---|
| 20080299101 | Cancer Treatment Resistance and Agents Modulating Such Resistance - The present invention concerns a method for detecting in vitro resistance of cancer cells to a treatment by detecting in the cancer cells supernumerary nucleolar organizer regions (NOR), whereby identification of the presence of supernumerary NOR in the cancer cells is indicative of treatment resistance. The present invention also concerns a method for defining the capacity of a candidate agent to modulate NOR genes number of cancer cells by contacting the cancer cells with a candidate agent for a time sufficient to permit modulation of NOR genes number; and observing whether NOR genes number increases or decreases in said cancer cells. The present invention also provides a candidate agent that modulates NOR genes number of cancer cells obtained by the method of the invention and a composition for treating and/or preventing a cancer in a patient, comprising said candidate agent. Such a candidate agent decreases the NOR genes number in said cancer cells. | 12-04-2008 |
| 20100004161 | Toll Like Receptor 4 Dysfunction and the Biological Applications Thereof - The present invention relates to an in vitro method of assessing the sensitivity of a subject to a treatment of cancer, which method comprises detecting the presence of a mutated Toll Like Receptor 4 (TLR4) nucleic acid or an abnormal TLR4 protein expression or activity in a sample from the subject, the presence of said mutated TLR4 nucleic acid or abnormal TLR4 expression or activity being indicative of a resistance to said treatment. The invention further provides compounds for treating or preventing a cancer in a subject having a mutated TLR4 nucleic acid or an abnormal TLR4 protein expression or activity. | 01-07-2010 |
| 20100015653 | Compounds Regulating Calreticulin, KDEL Receptor and/or ERP-57 Cell Surface Exposure and Uses Thereof to Evaluate the Efficiency of a Cancer Treatment - The present invention relates to a method for determining the susceptibility of a patient tumour cell to a cancer treatment, which method comprises the detection or measure of CRT, KDEL receptor and/or ERp57 on the surface of a tumour cell. | 01-21-2010 |
| 20100016235 | Inhibitors of Protein Phosphatase 1, GADD34 and Protein Phosphatase 1/GADD34 Complex, Preparation and Uses Thereof - The present invention relates to the use of a protein phosphatase inhibitor selected from an inhibitor of the catalytic subunit of the protein phosphatase 1 (PP1), an inhibitor of GADD34 and an inhibitor of the PP1/GADD34 complex to prepare a pharmaceutical composition to prevent or treat a cancer in a mammal, wherein the pharmaceutical composition is intended for administration in combination with a product used in a treatment of a cancer. | 01-21-2010 |
| 20100136137 | THERAPEUTIC COMBINATION OF A PANHER/VEGFR2 KINASE INHIBITOR AND A PLATINUM COMPOUND - This invention relates to a synergistic therapeutic combination of anti-cancer compounds which comprises a) a panHER/VEGFR2 kinase inhibitor, and b) a platinum compound, and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use. The invention also relates to treating certain cancers utilizing the combination of the invention. | 06-03-2010 |
| 20110229411 | USE OF P2X7 PATHWAY FOR ASSESSING THE SENSITIVITY OF A SUBJECT TO A CANCER TREATMENT - The present invention concerns methods for assessing the sensibility of a subject to an anticancer treatment, for screening compounds which are useful for treating a cancer and for determining the likelihood of a metastatic relapse in a subject. The methods are based on the finding that a non-functional P2X7-elicited NALP3 inflammasome pathway in a subject is indicative of a resistance to treatment. The invention further concerns methods for treating a cancer and for restoring the sensitivity of the subject to a cancer treatment. | 09-22-2011 |
| Patent application number | Description | Published |
|---|
| 20090071573 | PHOSPHATING SOLUTION WITH HYDROGEN PEROXIDE AND CHELATING CARBOXYLIC ACIDS - The invention relates to a phosphating solution and a process for the phosphating of metallic surfaces with aqueous, acidic phosphating solutions that comprise zinc and phosphate ions, at least one source of peroxide and one or more aliphatic chelating carboxylic acids containing 2 to 7 carbon atoms; the phosphating solution having a free acid content of one point or less. | 03-19-2009 |
| 20110041957 | OPTIMIZED PASSIVATION ON TI/ZR-BASIS FOR METAL SURFACES - The present invention relates to a chromium-free aqueous agent based on water-soluble compounds of titanium and/or zirconium and a source of fluoride ions, copper ions and metal ions selected from the group consisting of calcium, magnesium, aluminum, boron, zinc, iron, manganese and/or tungstene and to a method for the anti-corrosive conversion treatment of metal surfaces. The chromium-free aqueous agent is suitable for the treatment of various metal materials, joined in composite structures, amongst others of steel or galvanized steel or the alloys thereof or any combinations of said materials. Furthermore, surfaces of aluminum and alloys thereof can be treated in an anti-corrosive manner using the agent according to the invention. The anti-corrosive treatment is intended in particular as a pretreatment for a subsequent dip-coating. The invention further relates to a metallic substrate that was treated according to a predefined method sequence with the chromium-free agent according to the invention and to the use thereof, particularly in the automotive production of vehicle bodies. | 02-24-2011 |
| 20110062027 | OPTIMIZED ELECTROCOATING OF ASSEMBLED AND PARTLY PREPHOSPHATED COMPONENTS - A process for the anticorrosive treatment of metal components that have been heat-treated at a temperature of at least 100° C. and at least partially comprise zinc surfaces, wherein the surfaces of the component that consist of zinc already partially have a crystalline zinc phosphate layer, wherein the cleaned component is given an activating pretreatment with an acidic aqueous dispersion of insoluble phosphates having a pH of not less than 4 and the component is subsequently subjected to a phosphating conversion treatment before electrocoating is applied. The invention also comprises the use of metal components that have been treated in such a process, for the application of multilayer systems and in particular for the manufacture of bodies in automobile production. | 03-17-2011 |
| 20110189401 | SUCCESSIVE CORROSION-PROTECTING PRE-TREATMENT OF METAL SURFACES IN A MULTIPLE-STEP PROCESS - The present invention relates to a method for improving the corrosion-protecting pre-treatment of metal surfaces and using rinse water in a manner to conserve resources in such a corrosion-protecting pre-treatment, comprising a conversion treatment step using an aqueous composition comprising at least 50 ppm of the elements B, Si, Ti, Zr and/or Hf in the form of water-soluble compounds at a pH value of 3 to 5.5, wherein a minimum fraction of 10 ppm of the elements B, Si, Ti, Zr and/or Hf in the form of water-soluble compounds is present in the last pre-rinse step and a portion of the aqueous composition of the conversion treatment step is contained in the first post-rinse step. The resource-conserving use of the rinse water is accomplished according to the invention by way of a cascaded return of rinse water from the last rinse step to the first rinse step. The present invention also relates to a metallic component treated using the method according to the invention and to the use thereof in a process for applying a multi-coating system, in particular a paint system containing an organic binder, in industrial manufacturing. | 08-04-2011 |
